Certara sets range for PE-backed debut
December 4, 2020- Share:
Certara and its stockholders have revealed plans to sell nearly 24.4 million shares for between $19 and $22 apiece in the company's coming IPO, with a midpoint pricing set to raise about $500 million. EQT owns a 64.6% pre-IPO stake in the company and expects to retain a majority of its voting shares upon the completion of the offering. New Jersey-based Certara creates simulation software and other technology used in drug discovery and development.
- Share:
-
-
-
-